Dual Task Cost in the Upper Limb in Persons With Multiple Sclerosis

NCT ID: NCT02493166

Last Updated: 2016-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multiple sclerosis (MS) is a chronic, inflammatory, neurodegenerative disorder of the central nervous system, with more than 2.5 million people in the world. It is the most non-traumatic cause of disability in young and middle-aged adults.

Because the lesions are spread in the brains, there is a variety of symptoms. The most common symptom is the typical motor dysfunction. 66% of persons with MS, and even 81% of them after 15 years, have problems with movements in one or both upper extremities.

Also, 40 untill 70% of persons with Multiple Sclerosis have cognitive impairment. Although they are less visible, they can have a major determining influence on social or work-related domains. The most frequent cognitive dysfunctions are sustained attention, reduced speed of information processing, impaired memory and limited executive functions.

When a combination, of motor and cognitive task, is asked, the execution of these tasks could be difficult with the foregoing in mind. For example problems during chatting while cooking, typing a report at a meeting or watching television while ironing.

The dual-task paradigm assumes that the attention should be divided between two simultaneous tasks. A dual task cost (DTC) is a restriction in performance on each task, compared whit the separate task versus simultaneously.

Research on dual tasking with persons with MS has already studied extensively, but not specific on the upper limb. In 2015 Learmonth, Pilutti and Motl published an primary research on the DTC. They combined the movements of the upper limb with a cognitive task. The research showed a difference between Persons with MS and the control group. At methodological level, there is lacking on the randomization of tasks. That is an important bias because of the learning effect of the tasks. They used only one task for the upper limb; this isn't enough to generalize the concept of motor interference in Persons with MS.

The study has two research questions:

* Have Persons with MS a greater DTC compared with a healthy control group? The motor task is executed with the upper limb.
* Is there a difference on DTC in persons with MS depending on the motor task?

This research is an observational case-control study in which individuals with MS will be compared to a healthy control group. They will be two moments of assessments. On the first day the general performance of the persons will be measured, by using clinical evaluation tests and questionnaires. On the second day they will be tests on the dual tasks, specific a comparison between single versus simultaneously performed tasks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with Multiple sclerosis Dual task cost

Dual task cost (cognitive-motor interference), comparing single versus dual task performance (on both motor and cognitive task)

Group Type ACTIVE_COMPARATOR

dual task cost (cognitive-motor interference)

Intervention Type OTHER

comparing single versus dual task performance (on both motor and cognitive task)

Healthy volontiers Dual task cost

Dual task cost (cognitive-motor interference), comparing single versus dual task performance (on both motor and cognitive task)

Group Type ACTIVE_COMPARATOR

dual task cost (cognitive-motor interference)

Intervention Type OTHER

comparing single versus dual task performance (on both motor and cognitive task)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dual task cost (cognitive-motor interference)

comparing single versus dual task performance (on both motor and cognitive task)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of MS according to McDonald's criteria
* 18+
* Have no other neurological or orthopedic disorder of the upper limb or spine. They should have the possibility to actively participate in the research.
* Nine hole peg test, in which the cut-off value is set at 0.5 PEG / sec

Exclusion Criteria

* Patients are excluded with serious psychological problems.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AZ Klina

OTHER

Sponsor Role collaborator

University Hospital, Antwerp

OTHER

Sponsor Role collaborator

private practice physician De Barsy

UNKNOWN

Sponsor Role collaborator

Hasselt University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Peter Feys

prof. dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Feys, prof. dr.

Role: PRINCIPAL_INVESTIGATOR

Hasselt University

Joke Raats

Role: STUDY_CHAIR

AZ Klina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AZ Klina

Brasschaat, , Belgium

Site Status

Private practice physician De Barsy

Brasschaat, , Belgium

Site Status

Hasselt University

Diepenbeek, , Belgium

Site Status

UZ Antwerp

Edegem, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-PFE-JRA01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.